Global Transcranial Magnetic Stimulators Market Professional Survey Report 2019
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Transcranial Magnetic Stimulators Quarterly Market Size Analysis
- 2.1 Transcranial Magnetic Stimulators Business Impact Assessment - COVID-19
- 2.1.1 Global Transcranial Magnetic Stimulators Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Transcranial Magnetic Stimulators Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Transcranial Magnetic Stimulators Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Transcranial Magnetic Stimulators Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Transcranial Magnetic Stimulators Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Transcranial Magnetic Stimulators Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Transcranial Magnetic Stimulators Market
- 3.5 Key Manufacturers Transcranial Magnetic Stimulators Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Transcranial Magnetic Stimulators Segments, By Type
- 4.1 Introduction
- 1.4.1 STMS
- 1.4.2 PTMS
- 1.4.3 RTMS
- 1.4.4 nTMS
- 4.2 By Type, Global Transcranial Magnetic Stimulators Market Size, 2019-2021
- 4.2.1 By Type, Global Transcranial Magnetic Stimulators Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Transcranial Magnetic Stimulators Price, 2020-2021
5 Impact of Covid-19 on Transcranial Magnetic Stimulators Segments, By Application
- 5.1 Overview
- 5.5.1 Depression
- 5.5.2 Tinnitus
- 5.5.3 Alzheimer
- 5.5.4 Parkinson's Disease
- 5.5.5 Psychiatric Disorders
- 5.5.6 Headache
- 5.5.7 Stroke
- 5.5.8 Other
- 5.2 By Application, Global Transcranial Magnetic Stimulators Market Size, 2019-2021
- 5.2.1 By Application, Global Transcranial Magnetic Stimulators Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Transcranial Magnetic Stimulators Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Neuronetics
- 7.1.1 Neuronetics Business Overview
- 7.1.2 Neuronetics Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.1.3 Neuronetics Transcranial Magnetic Stimulators Product Introduction
- 7.1.4 Neuronetics Response to COVID-19 and Related Developments
- 7.2 Yiruide
- 7.2.1 Yiruide Business Overview
- 7.2.2 Yiruide Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.2.3 Yiruide Transcranial Magnetic Stimulators Product Introduction
- 7.2.4 Yiruide Response to COVID-19 and Related Developments
- 7.3 Magstim
- 7.3.1 Magstim Business Overview
- 7.3.2 Magstim Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.3.3 Magstim Transcranial Magnetic Stimulators Product Introduction
- 7.3.4 Magstim Response to COVID-19 and Related Developments
- 7.4 Brainsway
- 7.4.1 Brainsway Business Overview
- 7.4.2 Brainsway Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.4.3 Brainsway Transcranial Magnetic Stimulators Product Introduction
- 7.4.4 Brainsway Response to COVID-19 and Related Developments
- 7.5 Neurosoft
- 7.5.1 Neurosoft Business Overview
- 7.5.2 Neurosoft Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.5.3 Neurosoft Transcranial Magnetic Stimulators Product Introduction
- 7.5.4 Neurosoft Response to COVID-19 and Related Developments
- 7.6 eNeura
- 7.6.1 eNeura Business Overview
- 7.6.2 eNeura Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.6.3 eNeura Transcranial Magnetic Stimulators Product Introduction
- 7.6.4 eNeura Response to COVID-19 and Related Developments
- 7.7 MagVenture
- 7.7.1 MagVenture Business Overview
- 7.7.2 MagVenture Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.7.3 MagVenture Transcranial Magnetic Stimulators Product Introduction
- 7.7.4 MagVenture Response to COVID-19 and Related Developments
- 7.8 Remed
- 7.8.1 Remed Business Overview
- 7.8.2 Remed Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.8.3 Remed Transcranial Magnetic Stimulators Product Introduction
- 7.8.4 Remed Response to COVID-19 and Related Developments
- 7.9 Nexstim
- 7.9.1 Nexstim Business Overview
- 7.9.2 Nexstim Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.9.3 Nexstim Transcranial Magnetic Stimulators Product Introduction
- 7.9.4 Nexstim Response to COVID-19 and Related Developments
- 7.10 Dr. Langer Medical
- 7.10.1 Dr. Langer Medical Business Overview
- 7.10.2 Dr. Langer Medical Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.10.3 Dr. Langer Medical Transcranial Magnetic Stimulators Product Introduction
- 7.10.4 Dr. Langer Medical Response to COVID-19 and Related Developments
- 7.11 MAG & More
- 7.11.1 MAG & More Business Overview
- 7.11.2 MAG & More Transcranial Magnetic Stimulators Quarterly Production and Revenue, 2020
- 7.11.3 MAG & More Transcranial Magnetic Stimulators Product Introduction
- 7.11.4 MAG & More Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Transcranial Magnetic Stimulators Supply Chain Analysis
- 8.1.1 Transcranial Magnetic Stimulators Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Transcranial Magnetic Stimulators Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Transcranial Magnetic Stimulators Distribution Channels
- 8.2.2 Covid-19 Impact on Transcranial Magnetic Stimulators Distribution Channels
- 8.2.3 Transcranial Magnetic Stimulators Distributors
- 8.3 Transcranial Magnetic Stimulators Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Transcranial Magnetic Stimulators, including the following market information:
Global Transcranial Magnetic Stimulators Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Transcranial Magnetic Stimulators Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Transcranial Magnetic Stimulators Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Transcranial Magnetic Stimulators Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Neuronetics, Yiruide, Magstim, Brainsway, Neurosoft, eNeura, MagVenture, Remed, Nexstim, Dr. Langer Medical, MAG & More, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
STMS
PTMS
RTMS
nTMS
Based on the Application:
Depression
Tinnitus
Alzheimer
Parkinson's Disease
Psychiatric Disorders
Headache
Stroke
Other